takisbiotech

The Mannan Induced
Psoriatic Arthritis (MiP)

The mannan (Saccharomyces Cerevisiae) induced PsA model (MiP) in mice is a newly developed model in which both skin lesions resembling those seen in Ps as well as the joint inflammation of PsA can be found. Disease is mediated by TNF-a produced by macrophages which leads to T cell activation and IL-17A production. The increased level of IL-17A recruit neutrophils to joint and skin and results in an inflammatory response. Repeated mannan injections (every 7th day) give rise to a chronic relapsing disease.

Onset of joint and skin inflammation is seen within a few days after the mannan injection and slowly heals out after one week if not reactivated by a second mannan injection.

The_Mannan_induced_Psoriatic_Arthritis-c8e5adbf
STUDY ENDPOINT
  • Histopathologic analysis
  • Macroscopic scores (skin and arthritis scores)
  • Ear epidermal thickness
  • Blood collections and analysis
  • Stool collections (NGS analysis of microbiota)
  • Tissue collections
  • Cytokine analysis and other inflammatory markers (IL-6, IL-17a, TNFα, TGFβ)

VALIDATION DATA

Arthritis and skin scores in mannan-treated mice compared with not-treated mice.

Negative CTRL
PsA mannan 20mg
Representative H&E staining of ears section, inflammation scoring and epidermal ear thickness
Mannan_graph4-56a2021f